Ataraxis AI
PrivateLast Round
Early Funding
Apr 21, 2025
Est. Valuation
$68.4M
Total Funding Raised
$48.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ataraxis AI is a precision oncology company that develops AI-powered diagnostic tools to personalize cancer treatment selection and prognosis.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ataraxis AI Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Ataraxis AI Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Apr 21, 2025 | ||||
| Series A | Mar 5, 2025 | ||||
| Seed | Oct 31, 2024 |
Key People
Founding team and executive leadership
Ataraxis AI Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bertelsmann Investments | Series A |
| Floating Point | Series A |
| Founders Fund | Series A |
| Floating Point Advisors | Series A |
| Thiel Bio | Series A |
| Obvious Ventures | Series A, Seed |
| Floating Point Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 30, 2026
Ataraxis Breast CTX estimates individualized chemotherapy benefits for patients.
- Mar 12, 2026
AI pioneer Yann LeCun joins as an advisor.
Ataraxis AI Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ataraxis AI's valuation, stock price, and market status.